Refractory pityriasis rubra pilaris with good response after treatment with ustekinumab

J Dtsch Dermatol Ges. 2018 Aug;16(8):1022-1025. doi: 10.1111/ddg.13550. Epub 2018 Jun 27.

Authors

Raquel Aragón-Miguel¹, Marta Prieto-Barrios¹, Alba Calleja-Algarra¹, Virginia Velasco-Tamariz¹, Juan José Andres-Lencina¹, Pablo Ortiz-Romero², Verónica Monsálvez-Honrubia¹

Affiliations

¹ Department of Dermatology, Hospital Universitario 12 de Octubre, I+12 Research Institute, Madrid, Spain.
² Department of Dermatology, Hospital Universitario 12 de Octubre, I+12 Research Institute, Universidad Complutense, Madrid, Spain.

PMID: 29947473
DOI: 10.1111/ddg.13550

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Dermatologic Agents / therapeutic use*
Humans
Male
Pityriasis Rubra Pilaris / drug therapy*
Pityriasis Rubra Pilaris / pathology
Ustekinumab / therapeutic use*

Substances

Dermatologic Agents
Ustekinumab